Therapeutic Solutions International, Inc.
TSOI
$0.0001
$0.000.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.91% | -31.09% | -32.64% | -52.15% | -65.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.91% | -31.09% | -32.64% | -52.15% | -65.46% |
| Cost of Revenue | -59.61% | -56.89% | -50.14% | -53.53% | 49.69% |
| Gross Profit | 384.48% | 1.53% | -15.32% | -51.10% | -94.02% |
| SG&A Expenses | 98.76% | -6.41% | -16.04% | -23.87% | 4.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.85% | -21.55% | -30.05% | -40.18% | -29.01% |
| Operating Income | -50.49% | 21.07% | 29.94% | 39.42% | 26.29% |
| Income Before Tax | -29.84% | 28.37% | 37.49% | 42.66% | 28.99% |
| Income Tax Expenses | 43.75% | -4.17% | 43.75% | 43.75% | 0.00% |
| Earnings from Continuing Operations | -29.85% | 28.36% | 37.45% | 42.63% | 28.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,928.12% | 372.92% | 265.05% | -14.35% | -- |
| Net Income | 14.48% | 36.62% | 42.57% | 43.11% | 30.60% |
| EBIT | -50.49% | 21.07% | 29.94% | 39.42% | 26.29% |
| EBITDA | -55.74% | 24.55% | 33.12% | 44.81% | 30.58% |
| EPS Basic | 50.00% | 58.33% | 60.00% | 56.25% | 44.44% |
| Normalized Basic EPS | 60.00% | 50.00% | 50.00% | 55.56% | 54.55% |
| EPS Diluted | 50.00% | 58.33% | 60.00% | 56.25% | 44.44% |
| Normalized Diluted EPS | 60.00% | 50.00% | 50.00% | 55.56% | 54.55% |
| Average Basic Shares Outstanding | 47.80% | 42.63% | 33.84% | 25.31% | 18.07% |
| Average Diluted Shares Outstanding | 47.80% | 42.63% | 33.84% | 25.31% | 18.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |